Fetal haemoglobin, sickling, and thalassaemia: a therapeutic lead?
- PMID: 678797
- PMCID: PMC1605748
- DOI: 10.1136/bmj.2.6129.3-a
Fetal haemoglobin, sickling, and thalassaemia: a therapeutic lead?
Similar articles
-
Sickle cell-beta 0-thalassaemia in Saudi Arabia.Hum Hered. 1987;37(4):211-6. doi: 10.1159/000153705. Hum Hered. 1987. PMID: 2443440
-
Clinical manifestation and laboratory findings of sickle cell anaemia in association with alpha-thalassaemia in Saudi Arabia.Acta Haematol. 1985;74(3):155-60. doi: 10.1159/000206194. Acta Haematol. 1985. PMID: 2420134
-
Sickle cell-hereditary persistence of fetal haemoglobin and its differentiation from other sickle cell syndromes.Br J Haematol. 1988 May;69(1):89-92. doi: 10.1111/j.1365-2141.1988.tb07607.x. Br J Haematol. 1988. PMID: 2454649
-
Molecular biology of hemoglobin: its application to sickle cell anemia and thalassemia.Schweiz Med Wochenschr Suppl. 1991;43:51-4. Schweiz Med Wochenschr Suppl. 1991. PMID: 1726857 Review.
-
The molecular basis of hemoglobin disease.Annu Rev Genet. 1972;6:47-70. doi: 10.1146/annurev.ge.06.120172.000403. Annu Rev Genet. 1972. PMID: 4581487 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources